Optibrium
Optibrium’s in silico solutions for molecule design, optimisation and data analysis enable global drug discovery teams to prioritise compounds with the highest chance of success before committing to synthesis. Underpinned by rigorous, peer-reviewed science, our software platforms support both ligand- and structure-based design, turning complex data into actionable insights and confident decisions throughout hit-to-lead and lead optimisation.
